• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Methode Electronics Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    12/7/23 1:13:56 PM ET
    $AAMC
    $ABBV
    $AGX
    $AI
    Real Estate
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AAMC alert in real time by email

    Shares of Methode Electronics, Inc (NYSE:MEI) fell sharply during Thursday’s session following weak quarterly earnings.

    Methode Electronics posted adjusted earnings of 6 cents per share, missing market estimates of 12 cents per share. The company’s quarterly sales came in at $288.00 million versus expectations of $292.82 million, according to Benzinga Pro.

    Methode Electronics shares fell 14.2% to $20.92 on Thursday.

    Here are some other stocks moving in today's mid-day session.

    Gainers

    • Save Foods, Inc. (NASDAQ:SVFD) shares climbed 186.7% to $6.16 after the company highlighted targeting of US carbon credit market following acquisition of majority ownership in newly- formed Nitrousink Ltd.
    • Cyngn Inc. (NASDAQ:CYN) gained 90.4% to $0.4643 after the company announced the issuance of a new patent, US-11,837,089-B2, for the autonomous vehicle (AV) and driving solutions.
    • Barnes & Noble Education, Inc. (NYSE:BNED) shares climbed 31.9% to $1.3850 following upbeat quarterly earnings.
    • Hempacco Co., Inc. (NASDAQ:HPCO) shares climbed 28.8% to $0.4331 after the company announced it entered into an exclusive Master Distribution Agreement with CBDAY Global. Under the agreement, CBDAY will exclusively sell Hempacco's line of hemp and CBD products in India and Thailand.
    • MicroAlgo Inc. (NASDAQ:MLGO) shares gained 26% to $12.07. MicroAlgo shares jumped over 295% on Wednesday after the company announced it plans to establish a postgraduate training practice base.
    • Kewaunee Scientific Corporation (NASDAQ:KEQU) climbed 25.5% to $22.53 following second-quarter earnings.
    • Inogen, Inc. (NASDAQ:INGN) climbed 23.3% to $6.15.
    • Satellogic Inc. (NASDAQ:SATL) rose 22% to $1.9584. Uzma and Satellogic signed a multi-million dollar +3-year agreement to advance geospatial capabilities in Southeast Asia.
    • Fitell Corporation (NASDAQ:FTEL) gained 19.7% to $1.70.
    • Altisource Asset Management Corporation(NYSE:AAMC) gained 19.3% to $4.0213. Altisource Asset Management reported key ruling in Blackrock and PIMCO litigation.
    • Semtech Corporation (NASDAQ:SMTC) climbed 18.5% to $19.80 after the company reported third-quarter financial results and issued guidance.
    • Altimmune, Inc. (NASDAQ:ALT) gained 18.3% to $8.14.
    • Solid Biosciences Inc. (NASDAQ:SLDB) gained 17.6% to $4.0250. Solid Biosciences received FDA fast track designation for its SGT-003 duchenne muscular dystrophy gene therapy candidate.
    • JetBlue Airways Corporation (NASDAQ:JBLU) climbed 15.8% to $5.48 after the company said that demand for travel remains healthy, with close-in bookings outperforming expectations for both holiday peak and non-holiday travel periods since late October.
    • Siyata Mobile Inc. (NASDAQ:SYTA) rose 15.2% to $3.8001 after announcing $900,000 follow-on orders.
    • Verint Systems Inc. (NASDAQ:VRNT) gained 14% to $27.40 after the company reported better-than-expected third-quarter financial results and issued guidance.
    • Lilium N.V. (NASDAQ:LILM) gained 14% to $1.2650 after the company announced it signed a Memorandum of Understanding with Lufthansa Group for a strategic partnership.
    • AerSale Corporation (NASDAQ:ASLE) shares surged 13.4% to $16.16 after the company announced the FAA has issued the company a Supplemental Type Certificate for AerAware, its Enhanced Flight Vision System for the Boeing B737NG product line.
    • Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) gained 12.2% to $41.44 after AbbVie Inc. (NYSE:ABBV) announced it will acquire the company for a total equity value of approximately $8.7 billion.
    • IES Holdings, Inc. (NASDAQ:IESC) gained 11.8% to $79.68 following quarterly results.
    • Couchbase, Inc. (NASDAQ:BASE) rose 5.7% to $21.07 as the company reported upbeat results for its third quarter and issued strong revenue outlook for FY24.
    • Alphabet Inc. (NASDAQ:GOOGL) gained 5.1% to $136.62. Google made a significant announcement, launching Gemini AI, its most powerful AI model to date.

    Losers

    • Troika Media Group, Inc. (NASDAQ:TRKA) shares fell 74.8% to $0.4812 after the company announced it filed for Chapter 11.
    • Phio Pharmaceuticals Corp. (NASDAQ:PHIO) shares dipped 40% to $0.9462 as the company announced exercise of warrants for $2.8 million gross proceeds.
    • Bit Brother Limited (NASDAQ:BETS) fell 38.8% to $0.0214. Bit Brother recently announced the pricing of a $12 million registered direct offering.
    • FLJ Group Limited (NASDAQ:FLJ) fell 36% to $2.91.
    • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) shares tumbled 35.4% to $1.3789 after the company priced its $5 million public offering.
    • Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX) fell 32.8% to $1.25 as the company announced pricing of $4.5 million registered direct offering.
    • Red Cat Holdings, Inc. (NASDAQ:RCAT) shares fell 30.5% to $0.5280. Red Cat priced public offering of 16 million common shares at $0.50 per share for gross proceeds of $8 million.
    • Sprinklr, Inc. (NYSE:CXM) shares fell 29.4% to $11.76 following weak earnings for the third quarter.
    • Wave Life Sciences Ltd. (NASDAQ:WVE) shares fell 29.1% to $4.87 after the company priced its $100 million public offering of ordinary shares.
    • Nogin, Inc. (NASDAQ:NOGN) fell 26.3% to $0.1334 after the company entered Chapter 11 bankruptcy proceedings in combination with a stalking horse bid and Debtor in Possession financing provided by B. Riley Financial, Inc.
    • enGene Holdings Inc. (NASDAQ:ENGN) declined 23.8% to $7.87.
    • Sportsman's Warehouse Holdings, Inc. (NASDAQ:SPWH) fell 21.4% to $4.18. Sportsman's Warehouse said it sees fourth-quarter loss of 35 cents to 25 cents per share.
    • Phunware, Inc. (NASDAQ:PHUN) fell 19% to $0.1030 as the company reported pricing of $2.8 million public offering.
    • Nikola Corporation (NASDAQ:NKLA) fell 18.1% to $0.8047 after the company announced proposed offerings of common stock and convertible senior notes.
    • BAIYU Holdings, Inc. (NASDAQ:BYU) shares fell 17.7% to $1.49.
    • Vivid Seats Inc. (NASDAQ:SEAT) declined 15.6% to $6.87. Vivid Seats announced secondary offering of 18.5 million class A common stock.
    • Argan, Inc. (NYSE:AGX) fell 13.1% to $41.50 following downbeat earnings.
    • Liquidity Services, Inc. (NASDAQ:LQDT) dipped 12.8% to $17.36 following weak sales.
    • The Duckhorn Portfolio, Inc. (NYSE:NAPA) fell 10.7% to $9.11 following downbeat quarterly results.
    • C3.ai, Inc. (NYSE:AI) shares fell 9.8% to $26.30 after the company reported mixed second-quarter financial results and issued guidance.
    • Chewy, Inc. (NYSE:CHWY) fell 6% to $18.18 after the company reported mixed third-quarter financial results and cut FY23 net sales guidance.
    • Ollie's Bargain Outlet Holdings, Inc. (NASDAQ:OLLI) declined 5.5% to $72.09.
    • Greif, Inc. (NYSE:GEF) declined 5.5% to $65.83 following weak sales.
    • Veeva Systems Inc. (NYSE:VEEV) shares fell 4.1% to $171.20 after the company reported third-quarter financial results and issued guidance.

     

    Now Read This: 'I Like It Very Much': Jim Cramer Bullish On This Financial Stock Up 75% YTD

    Get the next $AAMC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAMC
    $ABBV
    $AGX
    $AI

    CompanyDatePrice TargetRatingAnalyst
    Wave Life Sciences Ltd.
    $WVE
    2/5/2026$38.00Buy
    BofA Securities
    JetBlue Airways Corporation
    $JBLU
    2/3/2026$6.00Sell → Neutral
    Citigroup
    enGene Holdings Inc.
    $ENGN
    1/30/2026$28.00Buy
    Jefferies
    Altimmune Inc.
    $ALT
    1/28/2026$20.00Overweight
    Barclays
    Alphabet Inc.
    $GOOGL
    1/26/2026$330.00 → $360.00Overweight
    KeyBanc Capital Markets
    Alphabet Inc.
    $GOOGL
    1/23/2026$333.00 → $346.00Buy
    Stifel
    Satellogic Inc.
    $SATL
    1/21/2026$5.00Buy
    Craig Hallum
    Veeva Systems Inc.
    $VEEV
    1/13/2026$215.00Sell
    Goldman
    More analyst ratings

    $AAMC
    $ABBV
    $AGX
    $AI
    SEC Filings

    View All

    SEC Form 10-K filed by JetBlue Airways Corporation

    10-K - JETBLUE AIRWAYS CORP (0001158463) (Filer)

    2/12/26 4:45:16 PM ET
    $JBLU
    Air Freight/Delivery Services
    Consumer Discretionary

    SEC Form 13F-HR filed by IES Holdings Inc.

    13F-HR - IES Holdings, Inc. (0001048268) (Filer)

    2/12/26 4:34:03 PM ET
    $IESC
    Engineering & Construction
    Industrials

    Amendment: SEC Form SCHEDULE 13G/A filed by Solid Biosciences Inc.

    SCHEDULE 13G/A - Solid Biosciences Inc. (0001707502) (Subject)

    2/12/26 9:09:34 AM ET
    $SLDB
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAMC
    $ABBV
    $AGX
    $AI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VYALEV issued to ABBVIE INC

    Submission status for ABBVIE INC's drug VYALEV (ORIG-1) with active ingredient FOSCARBIDOPA AND FOSLEVODOPA has changed to 'Approval' on 10/16/2024. Application Category: NDA, Application Number: 216962, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    10/18/24 4:38:13 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYALEV issued to ABBVIE INC

    Submission status for ABBVIE INC's drug VYALEV (ORIG-1) with active ingredient FOSCARBIDOPA AND FOSLEVODOPA has changed to 'Approval' on 10/16/2024. Application Category: NDA, Application Number: 216962, Application Classification: Type 3 - New Dosage Form

    10/17/24 1:29:31 PM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SKYRIZI issued to ABBVIE INC

    Submission status for ABBVIE INC's drug SKYRIZI (SUPPL-7) with active ingredient RISANKIZUMAB-RZAA has changed to 'Approval' on 06/18/2024. Application Category: BLA, Application Number: 761262, Application Classification:

    6/21/24 4:38:17 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAMC
    $ABBV
    $AGX
    $AI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Chief Human Resources Off Sathyanarayanan Bala bought $158,645 worth of Class B Common Stock (1,819 units at $87.22), increasing direct ownership by 27% to 8,549 units (SEC Form 4)

    4 - GREIF, INC (0000043920) (Issuer)

    2/11/26 5:15:33 PM ET
    $GEF

    President & CEO Read Rory P bought $152 worth of shares (20 units at $7.60) and sold $996,726 worth of shares (165,858 units at $6.01), decreasing direct ownership by 10% to 1,506,270 units (SEC Form 4)

    4 - Sprinklr, Inc. (0001569345) (Issuer)

    2/9/26 5:00:05 PM ET
    $CXM
    Computer Software: Prepackaged Software
    Technology

    EVP, Chief Human Resources Off Sathyanarayanan Bala bought $159,542 worth of Class B Common Stock (1,811 units at $88.10), increasing direct ownership by 37% to 6,730 units (SEC Form 4)

    4 - GREIF, INC (0000043920) (Issuer)

    2/6/26 4:47:40 PM ET
    $GEF

    $AAMC
    $ABBV
    $AGX
    $AI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    C3 AI to Announce Financial Results for Fiscal Third Quarter 2026 on February 25, 2026

    C3 AI (NYSE:AI) the Enterprise AI application software company, today announced it will issue its financial results for the fiscal third quarter, which ended January 31, 2026, following the close of the U.S. markets on Wednesday, February 25, 2026. C3 AI will host a conference call and webcast to discuss the financial results. The conference call will begin at 2:00 p.m. PST / 5:00 p.m. EST on February 25, 2026. Analysts and investors may participate in the question-and-answer session. Conference Call Details Date: Wednesday, February 25, 2026 Time: 2:00 p.m. Pacific Standard Time To access the conference call via a dial-in number and personalized PIN code, participants should regist

    2/12/26 9:00:00 AM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    Sprinklr Announces Date of Fourth Quarter and Full Year Fiscal 2026 Financial Results

    Sprinklr (NYSE:CXM), the definitive, AI-native platform for Unified Customer Experience Management (Unified-CXM), today announced that the company's fourth quarter and full year fiscal 2026 financial results will be released before market open on March 11, 2026. The company's earnings press release will be made available on the Sprinklr Investor Relations website at investors.sprinklr.com. Sprinklr will host a conference call to discuss its results at 8:30am ET the same day. Interested parties may register for and access the live webcast of the call at the website. To access the call by phone, dial 877-459-3955 (domestic) or / +1 201-689-8588 (international). The conference ID number is 1

    2/12/26 8:00:00 AM ET
    $CXM
    Computer Software: Prepackaged Software
    Technology

    EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight

    The EGFR-NSCLC market is expected to grow owing to the approval of new agents such as Zipalertinib (Cullinan Oncology/Taiho Pharma), Ivonescimab (Akeso Biopharma/Summit Therapeutics), Sacituzumab Tirumotecan (Merck/Kelun-Biotech), Izalontamab Brengitecan (Bristol-Myers Squibb), Firmonertinib (ArriVent BioPharma), and others in frontline and combination settings, rising therapy costs, and increasing testing rates that enable the identification of more patients with EGFR alterations. LAS VEGAS, Feb. 11, 2026 /PRNewswire/ -- DelveInsight's EGFR-NSCLC Market Insights report includes a comprehensive understanding of current treatment practices, EGFR-NSCLC emerging drugs, market share of individua

    2/11/26 5:31:00 PM ET
    $ABBV
    $AVBP
    $BDTX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $AAMC
    $ABBV
    $AGX
    $AI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $AAMC
    $ABBV
    $AGX
    $AI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    BofA Securities initiated coverage on Wave Life Sciences with a new price target

    BofA Securities initiated coverage of Wave Life Sciences with a rating of Buy and set a new price target of $38.00

    2/5/26 9:31:24 AM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    JetBlue Airways upgraded by Citigroup with a new price target

    Citigroup upgraded JetBlue Airways from Sell to Neutral and set a new price target of $6.00

    2/3/26 6:50:03 AM ET
    $JBLU
    Air Freight/Delivery Services
    Consumer Discretionary

    Jefferies initiated coverage on enGene Holdings with a new price target

    Jefferies initiated coverage of enGene Holdings with a rating of Buy and set a new price target of $28.00

    1/30/26 6:43:51 AM ET
    $ENGN
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Director Hennessy John L. gifted 1,765 units of Class C Capital Stock and received a gift of 1,765 units of Class C Capital Stock, decreasing direct ownership by 100% to 1 units (SEC Form 4)

    4 - Alphabet Inc. (0001652044) (Issuer)

    2/12/26 7:19:00 PM ET
    $GOOGL
    Computer Software: Programming Data Processing
    Technology

    Executive Chairman Siebel Thomas M exercised 511,732 shares at a strike of $2.04 and sold $5,966,795 worth of shares (511,732 units at $11.66) (SEC Form 4)

    4 - C3.ai, Inc. (0001577526) (Issuer)

    2/12/26 5:00:21 PM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    Chief Financial Officer Moran Kyle was granted 45,625 units of Ordinary Shares and sold $48,259 worth of Ordinary Shares (3,588 units at $13.45), increasing direct ownership by 46% to 134,385 units (SEC Form 4)

    4 - Wave Life Sciences Ltd. (0001631574) (Issuer)

    2/11/26 9:03:07 PM ET
    $WVE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAMC
    $ABBV
    $AGX
    $AI
    Leadership Updates

    Live Leadership Updates

    View All

    'Blue Sky' Reaches New Altitude: JetBlue and United Begin Offering Sales Across Both Airlines

    Starting this week, customers can book Blue Sky itineraries with cash or points and miles directly through JetBlue or United—unlocking broader access and a more seamless booking experience across both airlines. JetBlue (NASDAQ:JBLU) and United Airlines (NASDAQ:UAL) today announced the roll out of the next major customer benefit from their Blue Sky collaboration: beginning this week, travelers can start to purchase eligible itineraries operated by either airline directly on JetBlue.com, United.com and each airline's mobile app. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260210620738/en/Photo courtesy of JetBlue and United.

    2/10/26 2:00:00 PM ET
    $JBLU
    $UAL
    Air Freight/Delivery Services
    Consumer Discretionary

    Fitell Corporation Appoints AI and Robotics Executive Jack Zeng as Head of Technology at 2F Robotics to Accelerate Development and Commercialization Strategy

    Sydney, Australia, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Fitell Corporation (NASDAQ:FTEL) ("Fitell" or the "Company") announced today the appointment of Jack Zeng as the Head of Technology of 2F Robotics Pty Ltd, Fitell's robotics-focused subsidiary. Before joining Fitell, Mr. Zeng has founded and scaled successful technology ventures and brought experience in building data analytics and intelligent agent solutions for major enterprise customers including Fortune 500 across Asia, spanning product research and development, deployment, and go-to-market. With a background encompassing top-tier computer science education, Microsoft-certified engineering, and successful AI ventures, he has a track

    2/4/26 8:30:00 AM ET
    $FTEL
    Recreational Games/Products/Toys
    Consumer Discretionary

    Phio Pharmaceuticals Announces Participation in Third Annual DealFlow Discovery Conference

    Phio's Presentation to take place on Wednesday January 28, 2026 at 9 AM ETKing of Prussia, Pennsylvania--(Newsfile Corp. - January 26, 2026) - Phio Pharmaceuticals Corp. (NASDAQ:PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today announced that it will participate in the DealFlow Discovery Conference, taking place January 28-29, 2026 at the Borgata Hotel in Atlantic City, NJ.Robert Bitterman, CEO and Chairman of the Board of Phio Pharmaceuticals will deliver a company presentation on January 28th at 9 AM in Borgata Hotel Room #1 and the management team will be avai

    1/26/26 8:15:00 AM ET
    $PHIO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAMC
    $ABBV
    $AGX
    $AI
    Financials

    Live finance-specific insights

    View All

    C3 AI to Announce Financial Results for Fiscal Third Quarter 2026 on February 25, 2026

    C3 AI (NYSE:AI) the Enterprise AI application software company, today announced it will issue its financial results for the fiscal third quarter, which ended January 31, 2026, following the close of the U.S. markets on Wednesday, February 25, 2026. C3 AI will host a conference call and webcast to discuss the financial results. The conference call will begin at 2:00 p.m. PST / 5:00 p.m. EST on February 25, 2026. Analysts and investors may participate in the question-and-answer session. Conference Call Details Date: Wednesday, February 25, 2026 Time: 2:00 p.m. Pacific Standard Time To access the conference call via a dial-in number and personalized PIN code, participants should regist

    2/12/26 9:00:00 AM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    Sprinklr Announces Date of Fourth Quarter and Full Year Fiscal 2026 Financial Results

    Sprinklr (NYSE:CXM), the definitive, AI-native platform for Unified Customer Experience Management (Unified-CXM), today announced that the company's fourth quarter and full year fiscal 2026 financial results will be released before market open on March 11, 2026. The company's earnings press release will be made available on the Sprinklr Investor Relations website at investors.sprinklr.com. Sprinklr will host a conference call to discuss its results at 8:30am ET the same day. Interested parties may register for and access the live webcast of the call at the website. To access the call by phone, dial 877-459-3955 (domestic) or / +1 201-689-8588 (international). The conference ID number is 1

    2/12/26 8:00:00 AM ET
    $CXM
    Computer Software: Prepackaged Software
    Technology

    JetBlue to Participate in Fireside Chat at Barclays 43rd Annual Industrial Select Conference

    JetBlue Airways Corporation (NASDAQ:JBLU) will participate in a fireside chat at the Barclays 43rd Annual Industrial Select Conference on February 18th, 2026 at approximately 10:25 a.m. ET. A live, listen-only webcast of the call will be available on JetBlue's investor relations website at the following web address: http://investor.jetblue.com For those unable to listen to the live webcast, it will also be archived on JetBlue's investor relations website under 'Archived Events & Presentations' following the conference call. About JetBlue JetBlue is New York's Hometown Airline®, and a leading carrier in Boston, Fort Lauderdale-Hollywood, Los Angeles, Orlando and San Juan. JetBlue c

    2/11/26 4:30:00 PM ET
    $JBLU
    Air Freight/Delivery Services
    Consumer Discretionary

    $AAMC
    $ABBV
    $AGX
    $AI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Red Cat Holdings Inc.

    SC 13G/A - Red Cat Holdings, Inc. (0000748268) (Subject)

    12/6/24 4:32:04 PM ET
    $RCAT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13D/A filed by Satellogic Inc.

    SC 13D/A - Satellogic Inc. (0001874315) (Subject)

    11/27/24 4:30:03 PM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology

    Amendment: SEC Form SC 13D/A filed by Satellogic Inc.

    SC 13D/A - Satellogic Inc. (0001874315) (Subject)

    11/21/24 8:39:01 PM ET
    $SATL
    Radio And Television Broadcasting And Communications Equipment
    Technology